Incidence of inflammatory bowel disease in Finnish children, 1987-2003

Pieta Turunen1, Kaija-Leena Kolho, Anssi Auvinen

  • 1Pediatric Research Centre, University of Tampere, Tampere, Finland.

Insights

The incidence of pediatric inflammatory bowel disease (IBD) nearly doubled in Finland between 1987 and 2003. Surgery was frequently required early in the course of Crohn's disease and ulcerative colitis in children.

Area of Science:

  • Pediatric Gastroenterology
  • Epidemiology
  • Clinical Medicine

Background:

  • Rising incidence of inflammatory bowel disease (IBD) observed globally.
  • Pediatric IBD trends, particularly Crohn's disease (CD) and ulcerative colitis (UC), vary geographically.
  • Need for updated epidemiological data on pediatric IBD in specific populations.

Purpose of the Study:

  • To determine the incidence and clinical characteristics of pediatric IBD in Finland.
  • To analyze trends in IBD diagnoses from 1987 to 2003.
  • To describe treatment and surgical outcomes in children with IBD.

Main Methods:

  • Retrospective review of patient records from two major Finnish university hospitals.
  • Inclusion of 619,340 children (<18 years), representing 56% of the national pediatric population.
  • Collection of clinical, endoscopic, and histological data for all diagnosed IBD cases between 1987 and 2003.

Main Results:

  • A total of 604 pediatric IBD cases were diagnosed over 17 years.
  • Mean annual IBD incidence increased significantly from 3.9 to 7.0 per 100,000 children (P < 0.001).
  • Crohn's disease (34%) and ulcerative colitis (52%) were the main diagnoses; indeterminate colitis (14%) was more common in very young children (<3 years).
  • 21% of patients underwent surgery before age 18, with a median time of 1.8 years from diagnosis to first operation.

Conclusions:

  • Pediatric IBD incidence in Finland nearly doubled from 1987 to 2003.
  • Early surgical intervention is a common aspect of pediatric IBD management.
  • Indeterminate colitis is a significant diagnosis in infants and toddlers with IBD.
Abstract

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...